Skip to search formSkip to main contentSkip to account menu

adenovirus-interferon gamma TG1042

Known as: TG1042 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Adenovirus-interferon γ (TG1042) demonstrates good tolerance and efficacy in relapsing primary cutaneous lymphoma (PCL): Final results of a phase I/II multicentric trial.
7539 Background: Interferons (IFNs), which can offset the Th2 dominance associated with PCL have been successfully used to treat… 
2005
2005
Adenovirus-Interferon-g (TG1042) Demonstates Clinical Activity in Relapsing Primary Cutaneous Lymphoma (PCL): A Phase I/II Multicentric Trial.
PCL has been successfully treated with interferons (IFNs), which can offset the Th2 dominance associated with PCL. Intratumoral… 
2004
2004
Phase I/II study of adenovirus-interferon-γ (TG1042) in primary cutaneous lymphomas (CL).
3039 Background: CL has been successfully treated with interferons (IFNs), which can offset the Th2 dominance associated with CL… 
2004
2004
Intra-tumoral delivery of TG1024 (Adenovirus-Interleukin-2) or TG1042 (Adenovirus-Interferon-gamma) in combination with systemic chemotherapy: Pre-clinical studies in murine models
4605 Advanced solid tumors, such as melanoma and renal cell cancer, respond to systemic interleukin-2 (IL-2) and/or interferon… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)